Oxidative stress and advanced glycation end products (AGEs) formation are proposed as effective mechanisms in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). 1,25(OH)2D3 was proposed to have antioxidant, antiinflammatory and antiglycation properties. In this study, the effect of 1,25(OH)2 D3 treatment on oxidative stress parameters and AGEs levels together with hepatic histopathology was investigated in high fructose (HFr) or ethanol (EtOH)-treated rats. Rats were treated with fructose (30%) or ethanol (5-20%) in drinking water with and without 1,25(OH)2D3 treatment (5 µg/kg two times a week) for 8 weeks. Insulin resistance (IR), oxidative stress parameters, AGEs, triglyceride (TG) and hydroxyproline (Hyp) levels together with histopathology were investigated in the liver. 1,25(OH)2D3 decreased hepatic reactive oxygen species, lipid and protein oxidation products together with histopathological improvements in HFr- and EtOH-treated rats. 1,25(OH)2D3 treatment was observed to decrease significantly serum and hepatic AGEs in HFr group, and hepatic AGEs in EtOH group. Our results clearly show that 1,25(OH)2 D3 treatment may be useful in the alleviation of hepatic lesions for decreasing glycoxidant stress in both NAFLD and ALD models created by HFr- and EtOH-treated rats, respectively.
11 February 2026 in Clinical and Experimental Obstetrics & Gynecology
Background: Endometrial cancer (EC) is the second most common gynecological malignancy and remains a major contributor to morbidity and mortality among women worldwide. Current diagnostic and prognostic tools have limited accuracy, highlighting the need for reliable, non-invasive biomarkers. Non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), have emerged as promising candidates. This study aimed to investigate serum lncRNA HOXA transcript antisense RNA myeloid-specific 1 (HOTAIRM1) and miR-182-5p expression levels in EC and evaluate their diagnostic value and association with clinicopathological features. Methods: This prospective cohort study analyzed serum samples that were prospectively collected from 73 women with histologically confirmed EC and 76 controls with non-malignant gynecological conditions. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to quantify serum lncRNA HOTAIRM1 and miR-182-5p expression levels. Associations with clinicopathological parameters and diagnostic performance were evaluated. Results: Serum expression levels of lncRNA HOTAIRM1 were significantly higher in EC patients (median [interquartile range (IQR)]: 1.36 [0.74–3.37]) than in controls (1.03 [0.58–2.03]; p = 0.043), whereas miR-182-5p levels showed no significant difference (p = 0.327). Receiver operating characteristic (ROC) curve analysis demonstrated that serum lncRNA HOTAIRM1 had high specificity (93.2%) but low sensitivity (29.6%) for EC diagnosis. No significant associations were identified between either biomarker or clinicopathological variables (p > 0.05). Conclusions: This study provides one of the first evaluations of circulating lncRNA HOTAIRM1 and miR-182-5p in serum samples from patients with EC. Our findings suggest that serum lncRNA HOTAIRM1, but not miR-182-5p, may serve as a potential non-invasive biomarker for EC. Although its limited sensitivity restricts its role as a standalone diagnostic tool, its high specificity supports potential clinical relevance. These preliminary results should be interpreted with caution, as they represent an initial exploratory analysis of circulating lncRNA HOTAIRM1 and miR-182-5p in EC.
Intraoperative cyst fluid is readily available during the surgical treatment of cystic intracranial lesions but is rarely subjected to systematic optical analysis. We describe a practical workflow for ultraviolet-visible (UV-Vis) spectrophotometric evaluation of intracranial cyst fluid and report our initial technical experience. Cyst fluid samples obtained intraoperatively from 16 patients with cystic intracranial lesions were processed by centrifugation and analyzed using UV-Vis spectrophotometry across a wavelength range of 250-720 nm. Following preliminary assessment of undiluted specimens, a standardized 1:10 dilution protocol was implemented to avoid detector saturation and ensure reproducible spectral acquisition. Spectral profiles were evaluated descriptively and explored using principal component analysis. Standardized processing and UV-Vis acquisition were feasible in all samples. Undiluted specimens frequently exceeded the linear detection range of the spectrophotometer, whereas diluted samples yielded stable and reproducible absorbance spectra. Heterogeneous spectral profiles were observed across specimens, demonstrating the ability of the workflow to capture optical variability within cyst fluid samples. UV-Vis spectrophotometric analysis of intracranial cyst fluid can be performed using a simple and reproducible workflow based on routine laboratory equipment. This technical experience provides a framework for future investigations of the optical characteristics of cystic intracranial lesions.